Josa-Culleré Group

Caroline B. Gentz

I am originally from Brazil and received my PhD in Pharmaceutical Sciences from the Federal University of Rio Grande do Sul. My previous research focused on the synthesis of new kinase inhibitors and the evaluation of their biological activity in pediatric cell lines. At IQAC, I am currently developing innovative drug strategies to selectively target and eliminate cancer stem cells by exploiting the activity of the ALDH enzyme. In my free time I enjoy cooking and spending time in nature.

Scroll to Top